pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$BNTXBioNTech SE

$BNTX96.90+0.05%
Mainz, DEupdated 1d ago

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.

Website ↗SEC EDGAR ↗Yahoo Finance ↗
community read0 votes

🐶 often sniffed alongside

top 2
  • tagOncology3 co-mentions · 1 sources
  • tagBreast Cancer3 co-mentions · 1 sources
pipeline
7
marketed
0
phase 3
3
catalysts ytd
2
approvals ytd
0
recalls ytd
0

Pipeline(7)

pipeline depth7 products
Preclinical: 1Phase 2: 3Phase 3: 3
1Preclinical3Phase 23Phase 3
Phase 3
BNT-113
Recurrent Head And Neck Squamous Cell Carcinoma
Phase 3
pumitamig
Non-Small Cell Lung Cancer
Phase 3
trastuzumab pamirtecan
Endometrial Cancer
Phase 2
BNT-111
Metastatic Melanoma
Phase 2
DB-1311
Esophageal Squamous Cell Carcinoma (ESCC)
Phase 2
sacituzumab drozuntecan
Epithelial Ovarian Cancer
Preclinical
Urinary Tract Infections Program
Urinary Tract Infections

📅 Upcoming

Nov 3, 2026
earnings
$BNTX96.90+0.05%
in 29d
BioNTech SE earnings
BioNTech SE
→

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase3A Study of COVID-19 Vaccine(s) in Children and Adultsrecruitingn=700
  • phase3ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancerrecruitingn=558
  • phase3A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancerrecruitingn=480
  • phase2Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapyactive not recruitingn=110
  • phase2Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumorsrecruitingn=248
  • phase3Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancerrecruitingn=1,580
  • phase1A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIVrecruitingn=67
  • phase2A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy Peoplecompletedn=1,353

Insider activity

source: SEC Form 4

open-market buys + sells

  • Apr 22, 26SELLPoetting Sierk· Chief Operating Officer50,000 sh @ $110.56−$5.53M↗
🐶 Hiring Signal
next earnings Nov 3, 2026
No open roles indexed yet — view BioNTech SE jobs →

News

no news has mentioned this company yet
identifiers
ticker
$BNTX
SEC CIK
0001776985
country
DE
source
sec_tickers
top tags
Oncology6NSCLC1
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR
last refreshed 17m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?